Mucin Levels in Dry Eye and Normal Populations
NCT05911555 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2023-06-22
Summary
The purpose of this study is to evaluate changes in ocular mucin levels in response to a drying environment in subjects with dry eye disease as well as patients who report no history of dry eye disease.
It is expected that exposure to the dry environment will alter mucin levels in different ways when comparing the two groups.
Conditions
- Dry Eye
Sponsors & Collaborators
-
ORA, Inc.
lead INDUSTRY
Principal Investigators
-
Gail Torkildsen, MD
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2013-05-31
- Completion
- 2013-05-31
Countries
- United States
Study Locations
More Related Trials
-
A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model
NCT00814944 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2
-
Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
NCT03925727 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
NCT03334539 ·Status: COMPLETED ·Phase: PHASE2
-
Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye
NCT06364657 ·Status: TERMINATED
-
Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye
NCT01089985 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
NCT06411132 ·Status: TERMINATED
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
NCT01257607 ·Status: COMPLETED ·Phase: PHASE2
-
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
NCT00037661 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922 ·Status: TERMINATED ·Phase: PHASE2
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
Dry Eye Symptoms and Quality of Life
NCT01988597 ·Status: COMPLETED
-
Controlled Adverse Environment: A Pilot Study to Evaluate Tear Film Stability and Tear Evaporation
NCT01448356 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
NCT00335114 ·Status: COMPLETED ·Phase: NA
-
Ocular Surface Dry Eye Microbiome
NCT02306668 ·Status: UNKNOWN
-
Effect of Controlled Adverse Environment (CAE) on Tear Film Stability
NCT01547936 ·Status: COMPLETED
-
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503189 ·Status: COMPLETED ·Phase: PHASE3
-
PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms
NCT05825599 ·Status: COMPLETED ·Phase: NA
-
Ocular Surface Microbiome in Dry Eye Patients
NCT02161341 ·Status: COMPLETED
-
A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome
NCT02139033 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
NCT05896670 ·Status: COMPLETED ·Phase: PHASE2